Below is a detailed analysis of the quarterly data for Aster DM Healthcare Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
For Sales, as of Mar 2025, the value is 1,000.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,050.00 Cr. (Dec 2024) to 1,000.00 Cr., marking a decrease of 50.00 Cr..
For Expenses, as of Mar 2025, the value is 818.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 864.00 Cr. (Dec 2024) to 818.00 Cr., marking a decrease of 46.00 Cr..
For Operating Profit, as of Mar 2025, the value is 182.00 Cr.. The value appears to be declining and may need further review. It has decreased from 186.00 Cr. (Dec 2024) to 182.00 Cr., marking a decrease of 4.00 Cr..
For OPM %, as of Mar 2025, the value is 18.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 18.00%.
For Other Income, as of Mar 2025, the value is 5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Dec 2024) to 5.00 Cr., marking a decrease of 4.00 Cr..
For Interest, as of Mar 2025, the value is 32.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 31.00 Cr. (Dec 2024) to 32.00 Cr., marking an increase of 1.00 Cr..
For Depreciation, as of Mar 2025, the value is 64.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 62.00 Cr. (Dec 2024) to 64.00 Cr., marking an increase of 2.00 Cr..
For Profit before tax, as of Mar 2025, the value is 91.00 Cr.. The value appears to be declining and may need further review. It has decreased from 102.00 Cr. (Dec 2024) to 91.00 Cr., marking a decrease of 11.00 Cr..
For Tax %, as of Mar 2025, the value is 6.00%. The value appears to be improving (decreasing) as expected. It has decreased from 37.00% (Dec 2024) to 6.00%, marking a decrease of 31.00%.
For Net Profit, as of Mar 2025, the value is 86.00 Cr.. The value appears strong and on an upward trend. It has increased from 64.00 Cr. (Dec 2024) to 86.00 Cr., marking an increase of 22.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 1.58. The value appears strong and on an upward trend. It has increased from 1.14 (Dec 2024) to 1.58, marking an increase of 0.44.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
×
Quarterly Chart
Profit & Loss - Annual Report
Last Updated: March 7, 2025, 9:12 pm
Metric
Mar 2013
Mar 2014
Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
TTM
Sales
1,922
2,871
3,876
5,250
5,931
6,721
7,963
8,652
8,608
10,253
2,994
3,699
4,112
Expenses
1,660
2,421
3,370
4,805
5,582
6,089
6,886
7,187
7,506
8,720
2,547
3,124
3,392
Operating Profit
261
451
506
445
349
632
1,077
1,465
1,103
1,533
447
575
720
OPM %
14%
16%
13%
8%
6%
9%
14%
17%
13%
15%
15%
16%
18%
Other Income
11
19
23
25
453
177
-155
-158
53
51
353
32
5,125
Interest
45
48
79
189
371
204
205
391
334
307
96
119
121
Depreciation
76
111
144
243
322
298
306
586
618
641
192
220
243
Profit before tax
151
310
306
38
108
308
410
330
205
637
511
268
5,480
Tax %
4%
9%
11%
78%
10%
8%
10%
5%
13%
6%
7%
21%
Net Profit
149
284
272
8
98
282
367
315
178
601
475
212
5,320
EPS in Rs
7.26
4.69
7.00
0.20
2.52
5.32
6.59
5.54
2.96
10.53
8.51
2.59
105.60
Dividend Payout %
0%
35%
0%
0%
0%
0%
0%
0%
0%
0%
0%
77%
×
Profit & Loss Yearly Chart
YoY Net Profit Growth
Year
2013-2014
2014-2015
2015-2016
2016-2017
2017-2018
2018-2019
2019-2020
2020-2021
2021-2022
2022-2023
2023-2024
YoY Net Profit Growth (%)
90.60%
-4.23%
-97.06%
1125.00%
187.76%
30.14%
-14.17%
-43.49%
237.64%
-20.97%
-55.37%
Change in YoY Net Profit Growth (%)
0.00%
-94.83%
-92.83%
1222.06%
-937.24%
-157.61%
-44.31%
-29.32%
281.13%
-258.61%
-34.40%
Aster DM Healthcare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
Compounded Sales Growth
10 Years:
1%
5 Years:
-14%
3 Years:
-26%
TTM:
12%
Compounded Profit Growth
10 Years:
4%
5 Years:
-2%
3 Years:
-9%
TTM:
209%
Stock Price CAGR
10 Years:
%
5 Years:
41%
3 Years:
46%
1 Year:
57%
Return on Equity
10 Years:
8%
5 Years:
9%
3 Years:
8%
Last Year:
10%
Last Updated: Unknown
No data available for the Balance Sheet data table.
After reviewing the key financial ratios for Aster DM Healthcare Ltd, here is a detailed analysis based on the latest available data and recent trends:
For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 2.60. This value is below the healthy minimum of 5. It has decreased from 8.54 (Mar 23) to 2.60, marking a decrease of 5.94.
For Diluted EPS (Rs.), as of Mar 24, the value is 2.60. This value is below the healthy minimum of 5. It has decreased from 8.53 (Mar 23) to 2.60, marking a decrease of 5.93.
For Cash EPS (Rs.), as of Mar 24, the value is 8.87. This value is within the healthy range. It has decreased from 25.12 (Mar 23) to 8.87, marking a decrease of 16.25.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 100.70. It has increased from 89.81 (Mar 23) to 100.70, marking an increase of 10.89.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 100.70. It has increased from 89.81 (Mar 23) to 100.70, marking an increase of 10.89.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 74.05. It has decreased from 238.89 (Mar 23) to 74.05, marking a decrease of 164.84.
For PBDIT / Share (Rs.), as of Mar 24, the value is 12.07. This value is within the healthy range. It has decreased from 32.90 (Mar 23) to 12.07, marking a decrease of 20.83.
For PBIT / Share (Rs.), as of Mar 24, the value is 7.66. This value is within the healthy range. It has decreased from 17.28 (Mar 23) to 7.66, marking a decrease of 9.62.
For PBT / Share (Rs.), as of Mar 24, the value is 5.46. This value is within the healthy range. It has decreased from 10.69 (Mar 23) to 5.46, marking a decrease of 5.23.
For Net Profit / Share (Rs.), as of Mar 24, the value is 4.46. This value is within the healthy range. It has decreased from 9.49 (Mar 23) to 4.46, marking a decrease of 5.03.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 2.59. This value is within the healthy range. It has decreased from 8.51 (Mar 23) to 2.59, marking a decrease of 5.92.
For PBDIT Margin (%), as of Mar 24, the value is 16.29. This value is within the healthy range. It has increased from 13.77 (Mar 23) to 16.29, marking an increase of 2.52.
For PBIT Margin (%), as of Mar 24, the value is 10.34. This value is within the healthy range. It has increased from 7.23 (Mar 23) to 10.34, marking an increase of 3.11.
For PBT Margin (%), as of Mar 24, the value is 7.36. This value is below the healthy minimum of 10. It has increased from 4.47 (Mar 23) to 7.36, marking an increase of 2.89.
For Net Profit Margin (%), as of Mar 24, the value is 6.02. This value is within the healthy range. It has increased from 3.97 (Mar 23) to 6.02, marking an increase of 2.05.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 3.49. This value is below the healthy minimum of 8. It has decreased from 3.56 (Mar 23) to 3.49, marking a decrease of 0.07.
For Return on Networth / Equity (%), as of Mar 24, the value is 2.83. This value is below the healthy minimum of 15. It has decreased from 10.43 (Mar 23) to 2.83, marking a decrease of 7.60.
For Return on Capital Employeed (%), as of Mar 24, the value is 5.71. This value is below the healthy minimum of 10. It has decreased from 8.44 (Mar 23) to 5.71, marking a decrease of 2.73.
For Return On Assets (%), as of Mar 24, the value is 0.71. This value is below the healthy minimum of 5. It has decreased from 2.85 (Mar 23) to 0.71, marking a decrease of 2.14.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.09. This value is below the healthy minimum of 0.2. It has decreased from 0.32 (Mar 23) to 0.09, marking a decrease of 0.23.
For Total Debt / Equity (X), as of Mar 24, the value is 0.14. This value is within the healthy range. It has decreased from 0.56 (Mar 23) to 0.14, marking a decrease of 0.42.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.22. It has increased from 0.18 (Mar 23) to 0.22, marking an increase of 0.04.
For Current Ratio (X), as of Mar 24, the value is 1.25. This value is below the healthy minimum of 1.5. It has increased from 1.06 (Mar 23) to 1.25, marking an increase of 0.19.
For Quick Ratio (X), as of Mar 24, the value is 1.25. This value is within the healthy range. It has increased from 0.77 (Mar 23) to 1.25, marking an increase of 0.48.
For Interest Coverage Ratio (X), as of Mar 24, the value is 5.46. This value is within the healthy range. It has increased from 4.99 (Mar 23) to 5.46, marking an increase of 0.47.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.96. This value is below the healthy minimum of 3. It has increased from 2.44 (Mar 23) to 2.96, marking an increase of 0.52.
For Enterprise Value (Cr.), as of Mar 24, the value is 21,464.85. It has increased from 14,334.72 (Mar 23) to 21,464.85, marking an increase of 7,130.13.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 5.80. This value exceeds the healthy maximum of 3. It has increased from 1.20 (Mar 23) to 5.80, marking an increase of 4.60.
For EV / EBITDA (X), as of Mar 24, the value is 35.61. This value exceeds the healthy maximum of 15. It has increased from 8.72 (Mar 23) to 35.61, marking an increase of 26.89.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 5.53. This value exceeds the healthy maximum of 3. It has increased from 1.01 (Mar 23) to 5.53, marking an increase of 4.52.
For Price / BV (X), as of Mar 24, the value is 4.48. This value exceeds the healthy maximum of 3. It has increased from 2.96 (Mar 23) to 4.48, marking an increase of 1.52.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 5.53. This value exceeds the healthy maximum of 3. It has increased from 1.01 (Mar 23) to 5.53, marking an increase of 4.52.
For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 23) to 0.01, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
×
Profitability Ratios (%)
Liquidity Ratios
Liquidity Ratios (%)
Interest Coverage Ratios (%)
Valuation Ratios
Fair Value
Fair Value of Aster DM Healthcare Ltd as of June 13, 2025 is: 429.40
Calculation basis:
Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.
As of June 13, 2025, Aster DM Healthcare Ltd is Overvalued by 24.67% compared to the current share price 570.00
Intrinsic Value of Aster DM Healthcare Ltd as of June 13, 2025 is: 877.68
Calculation basis:
Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.
This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.
As of June 13, 2025, Aster DM Healthcare Ltd is Undervalued by 53.98% compared to the current share price 570.00
Last 5 Year EPS CAGR: 104.40%
*Investments are subject to market risks
Strength and Weakness
Unable to fetch valid data for stock valuation.
Stock Analysis
Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Aster DM Healthcare Ltd:
Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
ROE%: 2.83% (Industry Average ROE: 14.36%)
ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
Stock P/E: 74 (Industry average Stock P/E: 113.18)
Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
Total Debt / Equity: 0.14
Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions. Stock Rating:
About the Company - Qualitative Analysis
Aster DM Healthcare Ltd. is a Public Limited Listed company incorporated on 18/01/2008 and has its registered office in the State of Kerala, India. Company's Corporate Identification Number(CIN) is L85110KA2008PLC147259 and registration number is 021703. Currently Company is involved in the business activities of Hospital activities. Company's Total Operating Revenue is Rs. 2320.48 Cr. and Equity Capital is Rs. 499.52 Cr. for the Year ended 31/03/2025.
FAQ: Stock data is invalid or not in the correct format.
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Aster DM Healthcare Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
